Investigation announced for Long-Term Investors in shares of Praxis Precision Medicines, Inc. (NASDAQ: PRAX)

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Praxis Precision Medicines, Inc.

Investors who purchased shares of Praxis Precision Medicines, Inc. (NASDAQ: PRAX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Praxis Precision Medicines, Inc. (NASDAQ: PRAX officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Cambridge, MA based Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. On November 9, 2020, Praxis Precision Medicines, Inc. announced receipt of "a response from the U.S. Food and Drug Administration ("FDA") on the Investigational New Drug ("IND") submission for PRAX-114 for the treatment of major depressive disorder ('MDD')." Specifically, Praxis Precision Medicines, Inc. advised investors that "[a]t the end of the 30-day IND review period, the FDA notified the Company that the IND has been placed on full clinical hold. The FDA has not provided any reason for the clinical hold."

Shares of Praxis Precision Medicines, Inc. (NASDAQ: PRAX) declined from $38.42 per share on November 6, 2020 to as low as $28.03 per share on November 11, 2020.

Those who purchased shares of Praxis Precision Medicines, Inc. (NASDAQ: PRAX) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.